Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Volvo Cars reports new global sales record in 2024

Volvo Cars set a new global sales record as the company reports full-year sales of 763,389 cars during 2024, an increase of 8 per cent compared to the full year of 2023. For the month of December, Volvo Cars sold 73,804 cars globally, a decrease of 3 per cent compared to December 2023.   Volvo Cars also saw a significant increase in sales for its electrified cars. For the full year 2024, Volvo Cars sold 175,194 fully electric cars, an increase of 54 per cent compared to 2023, and 177,593 plug-in hybrid cars, a 16 per cent increase compared to 2023. Sales of electrified models

The Nomination Committee proposes Mikael Stöhr as the new Chair of the Board of Coor

The Nomination Committee has today informed Coor that the Chair of the Board Mats Granryd has decided not to stand for re-election to Coor's Board at the 2025 Annual General Meeting, and that the Nomination Committee proposes Mikael Stöhr as new Chair of the Board.Mikael Stöhr was President and CEO of Coor during the period March 2013 to July 2020 and was also a board member during the period May 2013 to July 2020. He is currently Chair of the board of Hjo Installation and board member of Werksta Group and was up to and including December 2024 President and CEO of Consolis Group. Mikael has

Carbiotix CEO reflects on 2024 and provides key milestones for 2025

Carbiotix AB (publ) ("Carbiotix" or “the Company") CEO Erik Deaner reflects on 2024 with regards to the strategic focus, sales & marketing, organization, and financials, and provides key milestones for 2025.Reflection of 2024“Now that 2024 has passed, I find it appropriate to reflect on the activities of this past year. 2024 was undoubtedly a transformative year for Carbiotix with the strategic decision to focus solely on the NutraCycle upcycling service. This decision was not only based on a thorough assessment of the Company’s strategic position in the marketplace, competitive

Consumer Test-Launch of SIGRID's Glucose Stabiliser proves major success

Over 91% of U.S. and Swedish customers surveyed report that the 100% natural GLP-1 companion product provides more stable glucose levels, reduces bloating, and curbs the urge to snack STOCKHOLM, SWEDEN — January 7th, 2025 — SIGRID Therapeutics, the innovative health tech company revolutionizing metabolic health, has successfully completed the test-launch phase for its groundbreaking dietary supplement, Glucose Stabiliser. This achievement underscores the product's immense commercial potential, fueled by strong market demand and exceptional customer retention.Since launching in the U.S.

Epiroc wins large order for autonomous surface mining equipment in Australia

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and construction industries, has won a large order from BHP for autonomous surface mining equipment to be used at an iron ore mine in Australia.BHP , one of the world’s largest mining companies, has ordered a fleet of Pit Viper 271 blasthole drill rigs that will be used at its Western Australia Iron Ore operations in the Pilbara region of Western Australia. The highly advanced machines will allow BHP operators to supervise

New publication highlights safety and potential benefits of redosing Diamyd® precision medicine for Type 1 Diabetes

Diamyd Medical announces the publication of the article titled "Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial" in the peer-reviewed journal International Journal of Molecular Sciences. The article describes the investigator-initiated clinical trial DIAGNODE-B, conducted in Linköping by Prof. Johnny Ludvigsson, which demonstrates the safety and potential efficacy of redosing Diamyd[®] (GAD-Alum), an antigen-specific immunotherapy aimed at preserving beta-cell function in Type 1 Diabetes. The trial included six participants carrying

TF Bank: Invitation to the presentation of the Year-end report 2024

TF Bank AB (publ) will publish its Year-end report for 2024 on Monday 20 January 2025 at 07.00 CET. We welcome media, institutional investors, analysts and other interested parties to participate in a conference call at 08.15 CET.  Agenda (CET)  07.00 – Year-end report published  08.15 – Conference call with CEO Joakim Jansson and CFO Mikael Meomuttel who will present the Year-end report. It will be possible to ask questions after the presentation.  To follow the conference call online go to www.tfbankgroup.com. To participate in the conference call, please click on the Zoom

Nordnet: Monthly statistics December

In December, Nordnet’s customers made 4,474,900 trades in listed financial instruments, which corresponds to 251,300 trades per day. New customers in December amounted to 24,500. The total number of new customers during 2024 is 256,900 gross and 234,051 net. The latter figure includes the sale of Nordnet’s unsecured lending portfolio to Ikano Bank on October 1. The total number of customers at the end of December was 2,096,900. Net savings for December was SEK 7.3 billion and the total net savings during 2024 is SEK 73.0 billion. The savings capital was SEK 1,032 billion and lending amounted

Wetteri Plc’s financial reporting and Annual General Meeting in 2025

Wetteri Plc Stock exchange release 7 January 2025 at 9.30Wetteri Plc will publish its financial reports in 2025 as follows:  · 13th March 2025: Financial statements bulletin for the 2024 financial year  · 24th April 2025: Annual report and financial statements for the 2024 financial year  · 19th May 2025: Interim report for January–March 2025  · 28th August 2025: Interim report for January–June 2025  · 20th November 2025: Interim report for January–September 2025  Wetteri Plc’s Annual General Meeting is scheduled to be held on 20th May 2025. The notice of the meeting

Hexagon to acquire Septentrio, revolutionising positioning in mission-critical navigation and autonomy applications

Hexagon today announced an agreement to acquire Septentrio NV, a leading OEM provider of Global Navigation Satellite System (GNSS) technologies, to drive innovation and expand the market reach of Resilient Assured Positioning solutions. Combining Septentrio's pioneering GNSS platform with Hexagon’s extensive positioning portfolio, including sensor fusion, anti-jamming, correction services and perception technologies, will enable cutting-edge solutions for diverse markets and applications. This will ensure greater accessibility to high-accuracy and high-performance positioning technology

Parys Mountain Mine Environmental Impact Assessment (EIA) Scoping Report Approved

    Trading Symbol AIM: AYM   7 January 2025   Anglesey Mining plc (“Anglesey” or “the Company”)   Parys Mountain Mine Environmental Impact Assessment (EIA) Scoping Report Approved    Further to the Company’s announcements on 16 August 2024 and 29 October 2024, Anglesey Mining plc (AIM:AYM), is pleased to announce that Cyngor Sir Ynys Môn/Anglesey County Council has recently approved the Parys Mountain Mine Environmental Impact Assessment (“EIA”) Scoping Report.   The North Wales Minerals and Waste Planning Service, on behalf of Cyngor Sir

Metso receives large filtration equipment order from India

Metso Corporation’s press release on January 07, 2025, at 09:00 a.m. EETMetso has received an order to deliver sustainable filtration technology for a long-distance iron ore slurry pipeline project. The technology will be used for concentrate filtration to produce iron ore pellets from pellet plants in India. The order value, which is not disclosed, is booked in the Minerals segment’s 2024 fourth-quarter orders received.   Metso’s scope of delivery consists of the engineering, manufacturing and supply of 16 Larox® FFP3512 filters, slurry feed and filtrate pumps, as well as installation

Skanska renovates environmental lab in Raleigh, North Carolina, USA, for USD 62M, about SEK 660M

Skanska has signed a contract with the North Carolina Department of Environmental Quality for the expansion and renovation of lab space in Raleigh, North Carolina. The contract is worth USD 62M, about SEK 660M, which will be included in the US order bookings for the fourth quarter 2024.The four-phase project will include a 3,100 square meter administration and visitor’s center which will connect two existing buildings, the construction of a new courtyard and the 4,900 square meter renovation of three existing buildings to create modular labs, new offices, and conference space. The project

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (3 January 2025)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 7 January 2025 at 8:15 EETStora Enso Oyj received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 6 January 2025. On 3 January 2025, BlackRock's holding, including holding through financial instruments, in Stora Enso’s shares increased above the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial instruments|in % (7.A

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

Bergen, Norway, January 7, 2025 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first patient has been included in a clinical trial sponsored by the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). The study is led by Josephine A. Taverna, MD, a thoracic oncologist at the Mays Cancer Center and Associate Professor in the Division of Hematology and Oncology at UT Health San Antonio.   “Dr. Taverna’s

Nordea Bank Abp: Repurchase of own shares on 06.01.2025

Nordea Bank AbpStock exchange release – Changes in company’s own shares06.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 06.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+------+-------------------+-------------------+| Trading |Number| Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares| ** | |+----------+------+-------------------+-------------------+|XHEL |0 |0.00 |0.00

SmartCraft ASA (SMCRT) - SmartCraft ASA completes share buyback program

6 January 2025 - With reference to the share buyback program announced 5 November 2024, SmartCraft ASA (”SmartCraft” or the ”Company”) (Ticker: SMCRT NO) has reached the buyback program’s maximum consideration of NOK 20 million as of 6 January 2025. Under the share buyback program the Company purchased 680,606 of its own shares in the period 5 November 2024 to 6 January 2025 at an average price of NOK 29.3855 per share for a total consideration of NOK 19,999,960.50. From 27 December 2024 until 6 January 2025, SmartCraft has purchased a total of 4,209 own shares at an average price of 29.

Buybacks of shares by Scandic during week 1, 2025

Between 30 December 2024 and 3 January 2025, Scandic Hotels Group AB (publ) (LEI: 529900JY9ZBGUXGRKQ86) has repurchased in total 195,000 own shares (ISIN: SE0007640156) as part of the share buyback program initiated by the Board of Directors.  The buybacks form part of the SEK 300 million share buyback program launched by Scandic on 9 December 2024. The share buyback program, which runs between 9 December 2024 and no later than 31 March 2025, is being carried out in accordance with the EU Market Abuse Regulation ("MAR") and the European Commission's Delegated Regulation 2016/1052 (the "

NRC Group ASA: Employee Share Purchase Program

NRC Group ASA ("NRC" or the "Company") has carried out its employee share purchase program for 2024. Participants in the share purchase program were offered a discount of 20 percent on the average closing price through the subscription period. Hence the subscription price after discount was NOK 4.24. In connection with the program, the Company has transferred 816,941 of its shares held in treasury to employees participating in the program. Following the transaction, NRC owns 339,306 treasury shares. The following primary insiders have purchased shares: Anders Gustafsson, CEO,

Circio Holding ASA: Requested Conversion of Convertible Bonds

Reference is made to Circio Holding ASA's (the "Company") outstanding convertible bonds as issued to Atlas Special Opportunities, LLC ("Atlas") under the Investment Agreement entered into between Atlas and the Company in March 2023. Atlas has, by a notice of conversion, requested conversion of convertible bonds with a nominal value of NOK 5,000,000 which, pursuant to the bond terms, are convertible into 7,714,858 new shares in the Company at a conversion price of NOK 0.6481. The Company's share capital will accordingly be increased by NOK 4,628,914.80 by the issuance of 7,714,858 new

Invitation to the presentation of Gjensidige's results for the 4th quarter 2024

Gjensidige Forsikring (OSE:GJF) will publish the results for the 4th quarter 2024 on 24 January at 7.00 CET. 24 January (Oslo) 9.00 CET CEO Geir Holmgren and CFO Jostein Amdal will present the results in a combined webcast and conference call. The presentation and following Q&A session will be held in English. The webcast can be viewed live on www.gjensidige.com/ir. Participants who would like to ask questions can dial in using one of the telephone numbers below. The full presentation can also be listened to live, using the same dial-in details. Dial-in details:Norway: +47

There are no items matching the current filter
There are no more items matching the current filter
Back to top